Published in Medical Letter on the CDC and FDA, November 25th, 2001
"In response to recent events, King has taken the necessary steps to significantly increase the production of Wycillin," said John M. Gregory, chairman and chief executive officer of King.
"Since Wycillin is the only available intramuscular penicillin G procaine injection indicated for the treatment of anthrax,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.